Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Lineage Commitment01:21

Lineage Commitment

4.0K
Commitment is the  process whereby stem cells:
4.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Disorders of Leukocytes01:27

Disorders of Leukocytes

1.8K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Azidothymidine potentiates the immunomodulatory function of interferon-α in adult T cell leukemia/lymphoma.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Scavenger receptor class B type I (SR-BI) as a potential therapeutic target in multiple myeloma.

Medical molecular morphology·2026
Same author

Idiopathic Multicentric Castleman Disease Presenting as Recurrent Acute-Onset Demyelinating Neuropathy.

Internal medicine (Tokyo, Japan)·2026
Same author

HTLV-1 subverts the innate immune effector gene IRF7 by viral HBZ protein for oncogenesis.

Nature communications·2026
Same author

IL-6-driven POU2AF1 and ELL2 are key regulators of multiple myeloma-distinct transcriptional and splicing programs.

Blood advances·2026
Same authorSame journal

[Nuclear Translocation of HTLV-1 bZIP Factor by Activation of the TGF-β/Smad Pathway: A Key Molecular Mechanism for HTLV-1 Oncogenesis].

Uirusu·2026

Related Experiment Video

Updated: May 1, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

8.6K

[HTLV-I and leukemogenesis].

Jun-ichirou Yasunaga1, Masao Matsuoka

  • 1Laboratory of Human Tumor Viruses Department of Viral Oncology Institute for Virus Research, Kyoto University. jyasunag@virus1.virus.kyoto-u.ac.jp

Uirusu
|April 21, 2007
PubMed
Summary

Human T-cell leukemia virus type I (HTLV-I) causes adult T-cell leukemia (ATL) through host cell proliferation, not viral replication. Both viral Tax and HBZ proteins, alongside host genetic factors, contribute to ATL development over a long latency period.

Area of Science:

  • Virology
  • Oncology
  • Immunology

Background:

  • Human T-cell leukemia virus type I (HTLV-I) is the causative agent of adult T-cell leukemia (ATL).
  • ATL is an aggressive CD4+ T lymphocyte cancer characterized by "flower cells".
  • HTLV-I promotes leukemogenesis via host cell clonal expansion rather than viral replication.

Purpose of the Study:

  • To elucidate the complex mechanisms underlying HTLV-I-induced leukemogenesis.
  • To investigate the roles of viral proteins (Tax and HBZ) and host factors in ATL development.
  • To understand the long latency period associated with ATL onset.

Main Methods:

  • Analysis of HTLV-I viral proteins, including Tax and HBZ.
  • Investigation of host genetic and epigenetic alterations.

More Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

23.7K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.8K

Related Experiment Videos

Last Updated: May 1, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

8.6K
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

23.7K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.8K
  • Evaluation of the host immune status in relation to leukemogenesis.

    • Main Results:

    • Tax protein, crucial for cell transformation, is often downregulated in fresh ATL cells.
    • HBZ, encoded by the complementary strand of HTLV-I, is implicated as a critical leukemogenic gene.
    • The multistep nature of ATL development suggests involvement of multiple factors.

    Conclusions:

    • Leukemogenesis of ATL is a complex, multistep process.
    • Viral proteins (Tax, HBZ), host genetic/epigenetic changes, and immune status are likely implicated.
    • Further research is needed to fully understand the interplay of these factors in ATL pathogenesis.